These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6590 related articles for article (PubMed ID: 2937529)

  • 21. Acute leukemia associated with the t(4;11) chromosome rearrangement: ultrastructural and immunologic characteristics.
    Parkin JL; Arthur DC; Abramson CS; McKenna RW; Kersey JH; Heideman RL; Brunning RD
    Blood; 1982 Dec; 60(6):1321-31. PubMed ID: 6958337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneous expression of melanoma-associated antigens and HLA antigens by primary and multiple metastatic lesions removed from patients with melanoma.
    Natali P; Bigotti A; Cavaliere R; Liao SK; Taniguchi M; Matsui M; Ferrone S
    Cancer Res; 1985 Jun; 45(6):2883-9. PubMed ID: 3157450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translocation (X;12)(p11;p13) as a sole abnormality in biphenotypic acute leukemia.
    Manola KN; Georgakakos VN; Marinakis T; Stavropoulou C; Paterakis G; Anagnostopoulos NI; Pantelias GE; Sambani C
    Cancer Genet Cytogenet; 2007 Mar; 173(2):159-63. PubMed ID: 17321333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interstitial pulmonary fibrosis as a complication of prolonged methyl-CCNU therapy.
    Lee W; Moore RP; Wampler GL
    Cancer Treat Rep; 1978 Sep; 62(9):1355-8. PubMed ID: 688278
    [No Abstract]   [Full Text] [Related]  

  • 25. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
    Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
    Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Philadelphia-chromosome-positive, monosomy 7 biphenotypic acute mixed lineage leukemia in adults: a pluripotent stem cell disorder.
    Hamaguchi H; Nakamura Y; Nagata K; Shiba S; Arimura H; Muroga K; Miyake S; Ohkawa Y; Morio T
    Leukemia; 1993 Nov; 7(11):1752-8. PubMed ID: 7901455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct antigen expression related to DNA ploidy in a case of biphenotypic leukemia.
    Paietta E; Andreeff M; Papenhausen P; Gucalp R; Wiernik PH
    Leukemia; 1989 Jan; 3(1):76-8. PubMed ID: 2909810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4;11 translocation-associated acute leukemia: a comprehensive analysis.
    De Braekeleer M; Lin CC
    Cancer Genet Cytogenet; 1986 Mar; 21(1):53-66. PubMed ID: 2935246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
    Carrel S; Schreyer M; Gross N; Zografos L
    Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Juvenile chronic myelogenous leukemia: surface antigen phenotyping by monoclonal antibodies and cytogenetic studies.
    Shannon K; Nunez G; Dow LW; Weinberg AG; Sato Y; Stastny P; Buchanan GR
    Pediatrics; 1986 Mar; 77(3):330-5. PubMed ID: 3513115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biphenotypic acute leukemia: a case report.
    Zucchini A; Fattori PP; Lanza F; Ferrari L; Bagli L; Imola M; Ravaioli A; Papa S
    J Biol Regul Homeost Agents; 2004; 18(3-4):387-91. PubMed ID: 15786709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Trisomy of chromosome 11 in a case of common ALL antigen-positive acute myeloblastic leukemia (FAB-M1)].
    Nakamura H; Jubashi T; Jinnai I; Sasagawa I; Itoyama T; Tokunaga S; Moriuchi Y; Sadamori N; Ichimaru M
    Rinsho Ketsueki; 1989 Dec; 30(12):2220-4. PubMed ID: 2533625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunologic phenotype of blast cells in the diagnosis of myeloblastic leukemias].
    Baryshnikov AIu; Volkova MA; Frenkel' MA; Tupitsyn NN; Morozova LF
    Ter Arkh; 1985; 57(5):98-100. PubMed ID: 3895550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methyl-CCNU in malignant melanoma--a divided dose schedule of administration.
    Wittes RE; Hong WK; Gatchell L; Krakoff IH; Golbey RB
    Oncology; 1977; 34(1):45-6. PubMed ID: 865760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Green SJ
    Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CALLA-positive myeloma: an aggressive subtype with poor survival.
    Durie BG; Grogan TM
    Blood; 1985 Jul; 66(1):229-32. PubMed ID: 3159443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
    Stöckbauer P; Malasková V; Soucek J; Chudomel V
    Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomes and causation of human cancer and leukemia. XXV. Significance of the Ph1 (including unusual translocations) in various acute leukemias.
    Oshimura M; Sandberg AA
    Cancer; 1977 Sep; 40(3):1149-60. PubMed ID: 332321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Abnormal phenotype of a chronic lymphatic leukemia: presence of T and B markers defined by monoclonal antibodies].
    Gómez Morales M; De Andrés MA; Garrido ML; Delgado C; Cabrera A; Garrido F
    Sangre (Barc); 1985; 30(3):348-54. PubMed ID: 3929410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 330.